Elderly Nutrition Market Poised to Register High Growth Due to Increasing Health Awareness Among Elderly Population

 

The elderly nutrition market comprises nutritional products meant to cater the nutritional needs of elderly population aged over 65 years. These products include both food and supplements which helps in managing common health issues among geriatric population like chronic diseases, weight management issues, bone and joint disorders. The need for specially formulated products for elderly arises due to factors like lower appetite, impaired digestive functioning and ability to absorb essential nutrients. Rising health concerns among geriatric population along with increasing population rate has fuelled the demand for elderly nutrition products globally.

The global elderly nutrition market is estimated to be valued at US$ 29048.57 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period of 2024 to 2030.

The increasing health awareness along with improving geriatric healthcare infrastructure is positively influencing the market growth. With growing number of nuclear families and working parents, ready-to-eat nutrition products cater well for independent living of elderly.

Key Takeaways

Key players operating in the elderly nutrition market are Amcor Limited, WestRock Company, Sonoco Products Company, Sealed Air Corporation, Stora Enso Oyj, Bemis Company, Inc., MULTIVAC, WS Packaging Group, Inc., Active Packaging Ltd., and ULMA Packaging, S.Coop. These players are focusing on new product launches and innovations in packaging to expand their market share.

The key opportunities in the elderly nutrition market lie in developing economies with increasing elderly population like China and India. These regions have low penetration of nutritional products for elderly currently. With improvement in healthcare spending and awareness, Asia Pacific presents huge growth potential over the forecast period.

The leading players are focusing on global expansion by targeting developed markets in North America and Europe through mergers and acquisitions. Companies are also eyeing opportunities in Middle East and Latin America for future business expansions.

Market Drivers

The primary driver boosting the Global elderly nutrition market size is increasing health awareness among aging population worldwide. Elderly are more concerned about managing illness and chronic conditions effectively through proper nutrition. Growing lifestyle diseases and disorders specific to geriatric population like diabetes, osteoporosis etc further drives the demand.

Market Restrains
High costs of formulated elderly nutrition products remains a major restraint in penetration of market globally. Affordability is a challenge in low and middle income economies. Lack of reimbursements for such products in developing regions also hampers the market growth.

Segment Analysis

The elderly nutrition market can be segmented into oral nutritional supplements and hypodermic products. Oral nutritional supplements dominate the market owing to ease of consumption and wider acceptance. Oral nutritional supplements are available in the form of powder, liquid, capsules and mousse, with powder nutritional supplement being the most popular sub-segment as they are easy to consume and require less preparation time.

Global Analysis

Regionally, North America dominates the elderly nutrition market and is expected to continue its dominance during the forecast period of 2024 to 2030. Higher health and nutrition awareness among the elderly population along with availability of varied products drives the North America market. Asia Pacific is projected to be the fastest growing region on account of rising geriatric population, growing health consciousness and increasing spending capacity on healthcare. Factors such as evolving lifestyles, rising chronic disease prevalence and awareness about disease management support nutrition supplements are contributing to growth of markets in Asia Pacific and Latin America regions.

Get More Insights On This Topic: https://www.ukwebwire.com/elderly-nutrition-market-size-share-analysis-2023-2030/


Comments

Post a Comment

Popular posts from this blog

Mantle Cell Lymphoma Treatment Market will generate new growth opportunities 2023-2030

Image
Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma (NHL) that arises from abnormal B lymphocytes (a type of white blood cell) known as mantle cells. It is considered an aggressive subtype of NHL, and its treatment typically involves a combination of different approaches, including chemotherapy, immunotherapy, targeted therapy, and stem cell transplantation. Here is a detailed overview of the treatment options for mantle cell lymphoma : Chemotherapy: Chemotherapy drugs are commonly used as the initial treatment for MCL. The specific chemotherapy regimens may vary, but commonly used combinations include R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), hyper-CVAD (cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with high-dose methotrexate and cytarabine), or Bendamustine combined with rituximab (BR). Chemotherapy is typically administered in cycles over several months. Immunotherapy: ...
Read more

Phosphodiesterase Enzyme (PDE) Inhibitors Market 2023 Report Contains Key Vendor Analysis, Vendor Landscape and Forecast to 2030

Image
Phosphodiesterase (PDE) inhibitors are a class of drugs that act on the phosphodiesterase enzymes , specifically the cyclic nucleotide phosphodiesterases. These enzymes are responsible for the degradation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which are important intracellular signaling molecules involved in various physiological processes. By inhibiting the activity of PDE enzymes, PDE inhibitors increase the levels of cAMP and cGMP in cells, leading to a variety of pharmacological effects. PDE inhibitors are used to treat a range of conditions, including erectile dysfunction, pulmonary arterial hypertension, and chronic obstructive pulmonary disease. They are available in different formulations, including oral tablets, sublingual tablets, and inhalers. There are several types of PDE enzymes, and PDE inhibitors are classified based on their selectivity for specific PDE enzyme subtypes. The major PDE inhibitors used in clinical practice ...
Read more

Enteral Nutrition Market will generate new growth opportunities 2023-2030

Image
Enteral nutrition is a method of providing nutrition directly into the gastrointestinal tract. It involves the delivery of a liquid formula containing nutrients through a tube, which can be inserted through the nose (nasogastric or nasoenteric tube) or directly into the stomach or small intestine (gastrostomy or jejunostomy tube). Enteral nutrition is typically used when a person is unable to consume an adequate amount of food orally or has a dysfunctional or non-functioning gastrointestinal tract. It may be used in various medical conditions such as: Inability to swallow: Patients who have difficulty swallowing due to conditions like stroke, neurological disorders, or head and neck cancers may require enteral nutrition to ensure adequate nutrition. Gastrointestinal disorders: Individuals with conditions such as Crohn's disease, short bowel syndrome, or malabsorption disorders may have difficulty absorbing nutrients from food, and enteral nutri...
Read more